BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6258925)

  • 1. Elicitation of primary anti-Sendai virus cytotoxic T lymphocytes with purified viral glycoproteins.
    McGee M; Hale AH; Panetti M
    Eur J Immunol; 1980 Dec; 10(12):923-8. PubMed ID: 6258925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elicitation of anti-viral cytotoxic T lymphocytes with purified viral and H-2 antigens.
    Hale AH; Ruebush MJ; Harris DT
    J Immunol; 1980 Jul; 125(1):428-30. PubMed ID: 6247399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elicitation of anti-Sendai virus cytotoxic T lymphocytes by viral and H-2 antigens incorporated into the same lipid bilayer by membrane fusion and by reconstitution into liposomes.
    Hale AH; Lyles DS; Fan DP
    J Immunol; 1980 Feb; 124(2):724-31. PubMed ID: 6243330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elicitation of anti-H-2 cytotoxic T lymphocytes with antigen-modified H-2 negative stimulator cells.
    Hale AH; Ruebush MJ; Harris DT; McGee MP
    J Immunol; 1981 Apr; 126(4):1485-8. PubMed ID: 6970778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactive anti-vesicular stomatitis virus (VSV) cytotoxic T lymphocytes recognize the major surface glycoprotein.
    Hale AH; Ruebush MJ; Lefrançois L
    Eur J Immunol; 1981 May; 11(5):434-6. PubMed ID: 6266837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-liposome modification of target cells as a method to alter their susceptibility to lysis by cytotoxic T lymphocytes.
    Hale AH; Ruebush MJ; Lyles DS; Harris DT
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6105-8. PubMed ID: 6255476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal molecular requirements for reactivity of tumor cells with T cells.
    Hale AH; Lyles DS; Paulus LK; Ruebush MJ
    J Immunol; 1980 May; 124(5):2063-70. PubMed ID: 6245133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of virus-specific cytotoxic T cells in vitro. I. Induction conditions of primary and secondary Sendai virus-specific cytotoxic T cells.
    Koszinowski UH; Simon MM
    Eur J Immunol; 1979 Sep; 9(9):715-22. PubMed ID: 92413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes.
    Harris DT; Hale AH; Lefrancois L
    J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of virus specific cytotoxic T cells in vitro. III. Spleen cells stimulated by viral antigens generate alloreactive cytotoxic T cells.
    Koszinowski U; Greber D; Neuschaefer-Rube I
    Immunobiology; 1979 Aug; 156(1-2):83-95. PubMed ID: 232074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of H-2-specific antibodies by injections of syngeneic Sendai virus-coated cells.
    Kievits F; Rocca A; Opolski A; Limpens J; Leupers T; Kloosterman T; Boerenkamp WJ; Pla M; Ivanyi P
    Eur J Immunol; 1987 Jan; 17(1):27-35. PubMed ID: 3028822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type-1 and Sendai virus important for membrane fusion.
    Bousse T; Takimoto T; Gorman WL; Takahashi T; Portner A
    Virology; 1994 Nov; 204(2):506-14. PubMed ID: 7941317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T-lymphocyte reactivity with individual Sendai virus glycoproteins.
    Al-Ahdal MN; Nakamura I; Flanagan TD
    J Virol; 1985 Apr; 54(1):53-7. PubMed ID: 2983119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against rabies in mice by a cytotoxic T cell clone recognizing the glycoprotein of rabies virus.
    Kawano H; Mifune K; Ohuchi M; Mannen K; Cho S; Hiramatsu K; Shichijo A
    J Gen Virol; 1990 Feb; 71 ( Pt 2)():281-7. PubMed ID: 2307962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell-mediated cytotoxic immune responsiveness of chimeric mice bearing a thymus graft fully allogeneic to the graft of lymphoid stem cells.
    Wagner H; Röllinghoff M; Rodt H; Thierfelder S
    Eur J Immunol; 1980 Jul; 10(7):521-5. PubMed ID: 6250856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary in vitro sensitization of virus specific cytotoxic T lymphocytes.
    Jung H; Pfizenmaier K; Starzinski-Powitz A; Röllinghoff M; Wagner H
    Immunology; 1978 Apr; 34(4):763-9. PubMed ID: 82534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of virus-specific cytotoxic T cells in vitro. II. Induction requirements with functionally inactivated virus preparations.
    Koszinowski UH; Gething MJ
    Eur J Immunol; 1980 Jan; 10(1):30-5. PubMed ID: 6244963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of cytolytic T cells by isolated viral peptides and HN protein coupled to agarose beads.
    Guertin DP; Fan DP
    Nature; 1980 Jan; 283(5744):308-11. PubMed ID: 6153234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity to herpes simplex virus: induction of cytotoxic T lymphocyte responses by viral antigens incorporated into liposomes.
    Lawman MJ; Naylor PT; Huang L; Courtney RJ; Rouse BT
    J Immunol; 1981 Jan; 126(1):304-8. PubMed ID: 6969745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elicitation of anti-vesicular stomatitis virus cytotoxic T lymphocytes by using purified viral and cellular antigens incorporated into phospholipid vesicles.
    Ruebush MJ; Hale AH; Harris DT
    Infect Immun; 1981 May; 32(2):513-7. PubMed ID: 6265359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.